The Automated Daily - Top News Edition

Triple-action cancer jab breakthrough & Pig-to-human multi-organ transplant - News (May 31, 2026)

Please support this podcast by checking out our sponsors: - Discover the Future of AI Audio with ElevenLabs - https://try.elevenlabs.io/tad [https://try.elevenlabs.io/tad] - Consensus: AI for Research. Get a free month - https://get.consensus.app/automated_daily [https://get.consensus.app/automated_daily] - Prezi: Create AI presentations fast - https://try.prezi.com/automated_daily [https://try.prezi.com/automated_daily] Support The Automated Daily directly: Buy me a coffee: https://buymeacoffee.com/theautomateddaily [https://buymeacoffee.com/theautomateddaily] TODAY'S TOPICS: TRIPLE-ACTION CANCER JAB BREAKTHROUGH - DOCTORS REPORTED STRIKING RESPONSES FROM AMIVANTAMAB, A TRIPLE-ACTION INJECTION FOR RECURRENT OR METASTATIC HEAD AND NECK CANCER, WITH COMPLETE TUMOUR CLEARANCE IN SOME PATIENTS AND MOSTLY MANAGEABLE SIDE EFFECTS. PIG-TO-HUMAN MULTI-ORGAN TRANSPLANT - CHINESE RESEARCHERS REPORTED THE FIRST COMBINED XENOTRANSPLANT OF A WHOLE PIG LIVER PLUS TWO PIG KIDNEYS INTO A HUMAN (BRAIN-DEAD RECIPIENT), SHOWING EARLY ORGAN FUNCTION BUT ALSO EARLY REJECTION SIGNALS AND NEW IMMUNE TARGETS LIKE S100A12+ CELLS. BREAST CANCER TEST SKIPPING CHEMO - THE OPTIMA TRIAL FOUND A GENOMIC TEST (PROSIGNA, 50-GENE ACTIVITY SCORE) CAN HELP MANY HORMONE-POSITIVE BREAST CANCER PATIENTS SAFELY AVOID CHEMOTHERAPY AFTER SURGERY, REDUCING TOXIC SIDE EFFECTS WITHOUT HURTING FIVE-YEAR OUTCOMES. TRUMP-IRAN TALKS ON HORMUZ - PRESIDENT DONALD TRUMP SAID HE’S MAKING A “FINAL DETERMINATION” ON A DRAFT IRAN AGREEMENT TIED TO A CEASEFIRE EXTENSION AND REOPENING THE STRAIT OF HORMUZ, WHILE TEHRAN SAYS NO DEAL IS FINALIZED—RAISING BIG IMPLICATIONS FOR OIL MARKETS AND SANCTIONS. UKRAINE DRONES HIT RUSSIAN OIL - UKRAINIAN LONG-RANGE DRONES REPORTEDLY SET FIRES AT RUSSIAN OIL FACILITIES IN ROSTOV AND KRASNODAR, UNDERSCORING KYIV’S GROWING STRIKE REACH AND THE WIDER RISK OF SPILLOVER AFTER A STRIKE INJURED PEOPLE IN NATO MEMBER ROMANIA. AI AND LAB-GROWN BRAIN CELLS - CORTICAL LABS TRAINED LAB-GROWN HUMAN NEURONS ON A CHIP TO PLAY DOOM, A STEP BEYOND EARLIER PONG EXPERIMENTS, FUELING DEBATE AND INTEREST IN ULTRA-LOW-POWER ‘BIOLOGICAL COMPUTING’ AND NEW RESEARCH TOOLS FOR DISEASE AND DRUG TESTING. AI TOOLS HELPING MUSICIANS CREATE - SINGER-SONGWRITER SAMUEL SMITH, LIVING WITH PARKINSON’S, USED AI MUSIC-GENERATION TOOLS TO SHAPE ARRANGEMENTS AND COMMUNICATE CREATIVE INTENT, SHOWING HOW AI CAN ACT AS AN ASSISTIVE TECHNOLOGY FOR ARTISTS FACING PHYSICAL LIMITS. NVIDIA’S AI BOOM AND POWER - NVIDIA, GUIDED IN PART BY CFO COLETTE KRESS, IS RESHAPING AROUND AI INFRASTRUCTURE DEMAND AS REVENUE AND CASH FLOW SURGE—HIGHLIGHTING HYPERSCALER DEPENDENCE AND THE BROADER GLOBAL RACE TO BUILD OUT AI CAPACITY. RUSSIA SIGNS PACT WITH TALIBAN - RUSSIA AND AFGHANISTAN’S TALIBAN AUTHORITIES SIGNED A MILITARY-TECHNICAL COOPERATION AGREEMENT, THE TALIBAN’S FIRST FORMAL DEFENCE PACT ABROAD, SIGNALING SHIFTING REGIONAL ALIGNMENTS AFFECTING PAKISTAN, INDIA, AND CENTRAL ASIA. Episode Transcript Triple-action cancer jab breakthrough Let’s start in medicine, where cancer researchers are reporting eye-catching results from an international trial of amivantamab in head and neck cancer. This was a tough group: patients with recurrent or metastatic disease whose cancers had already stopped responding to chemotherapy and immunotherapy. In the study, tumours shrank or disappeared in a substantial share of participants—and in a smaller but notable number, doctors reported the tumours were wiped out completely. Some changes showed up within weeks. Why it’s interesting: head and neck cancers that reach this stage, often HPV-negative, have limited remaining options. This drug also comes as a simple injection under the skin every three weeks, which could make treatment less burdensome than repeated IV infusions. Side effects were mostly described as mild to moderate, and relatively few people had to stop treatment. The data are being presented at the American Society of Clinical Oncology meeting, and researchers say the same drug is also showing promise in other cancers, including lung cancer. Pig-to-human multi-organ transplant Staying with health news, researchers in China say they’ve completed the first transplant of both a whole pig liver and two pig kidneys into a human—using organs from a genetically modified pig. The recipient was a 53-year-old man who had been declared brain-dead, and the team maintained organ function for nearly five days to observe what happened. Early signs were encouraging: the liver began producing bile, and kidney-related waste products in the blood returned to normal levels. But the study also underscores the main obstacle in xenotransplantation: rejection. Within roughly a day and a half, the researchers saw early immune-related damage and clotting in the pig liver, along with signs of the human body pushing back. They also flagged a specific inflammatory immune-cell signal that could become a future drug target. Why it matters: donor organ shortages remain severe worldwide. This kind of multi-organ experiment pushes the field beyond single-organ tests—but it also highlights that long-term survival still hinges on solving immune rejection. Breast cancer test skipping chemo Another big development in cancer care: an international trial suggests many patients with hormone-positive breast cancer could safely skip chemotherapy after surgery, using a genomic test to guide decisions. In the Optima study, researchers used the Prosigna test, which looks at the activity of a set of tumour genes to estimate the risk of recurrence. Patients with low-risk scores received hormone therapy alone, while higher-risk patients got chemotherapy plus hormone therapy. The headline result: outcomes for the low-risk group who avoided chemotherapy were essentially as strong as those who received the standard chemo approach. After five years, the vast majority were alive and recurrence-free. Why it’s interesting: it’s a shift away from one-size-fits-many treatment decisions, and toward tumour biology—potentially sparing large numbers of patients the long-term toxicities of chemo, while focusing resources on those most likely to benefit. These findings, too, are slated for presentation at ASCO. Trump-Iran talks on Hormuz Now to geopolitics and markets: President Donald Trump says he’s making a “final determination” on a proposed agreement with Iran, aimed at extending a fragile ceasefire and reopening the Strait of Hormuz. Iranian officials, however, say no deal has been finalized. Trump publicly set out demands: Iran pledging it will never obtain a nuclear weapon, immediate reopening of Hormuz for shipping without fees, and clearing any remaining mines—paired with the U.S. lifting its counter-blockade. He also claimed the U.S. would work with Iran and the International Atomic Energy Agency to recover and destroy highly enriched uranium from sites damaged in earlier U.S. strikes. Tehran’s message is more cautious: officials say messages are being exchanged, but they describe Washington’s conditions as excessive and inconsistent. Iranian media aligned with hardliners are pushing for frozen assets to be released as a precondition for further talks. Why it matters: Hormuz is one of the world’s most critical shipping chokepoints, typically carrying around a fifth of global oil. Even the possibility of a deal has already nudged crude prices downward this week—showing how sensitive markets are to any hint of stability. Ukraine drones hit Russian oil Turning to the war in Ukraine: Ukrainian drones sparked fires at Russian oil facilities overnight, with officials reporting damage in the Rostov and Krasnodar regions. Ukraine’s president, Volodymyr Zelenskyy, highlighted the distance involved—suggesting Kyiv is increasingly able to reach deeper into Russian territory. The strategy is straightforward: target oil assets that help fund Russia’s invasion and complicate logistics. At the same time, Russia continues long-range attacks on Ukrainian cities and infrastructure, and Kyiv says it’s bracing for more systematic strikes. Zelenskyy is again pressing the United States for additional Patriot air defenses. Two related notes raise the temperature: a Russian drone strike reportedly injured two people in Romania, a NATO member, fueling concerns about spillover; and Russia’s Rosatom said a Ukrainian drone hit the Russian-controlled Zaporizhzhia nuclear power plant, causing minor structural damage. No critical equipment was reportedly affected, but it’s another reminder of the ongoing nuclear safety risk that international monitors keep warning about. AI and lab-grown brain cells On the frontier where biology meets computing, researchers at Melbourne-based Cortical Labs say they’ve trained lab-grown human brain cells living on a silicon chip to play the classic shooter game Doom. The neurons—grown from stem cells derived from donated blood—were fed game information as patterns of electrical stimulation. Early on, the play looked chaotic, but over time the cells began to behave in ways that suggested learning, like better targeting. Why this is interesting: it’s not about building a gamer in a dish. It’s a signal that living neural tissue can adapt in real time to feedback, in a tightly controlled setup. The team argues the same platform could help with drug screening, disease modeling, and exploring new hybrid approaches to learning that could one day be more energy-efficient than conventional computing—though it’s still early, inconsistent, and limited by the short lifespan of the cell cultures. AI tools helping musicians create AI is also showing up in a more human setting: music. London-based singer-songwriter Samuel Smith, diagnosed with Parkinson’s disease in 2020, has turned to AI tools as the condition has reduced his ability to play guitar. On his new album, he used AI-generated demo arrangements to help communicate the structure and feel he wanted—so other musicians could record the final parts. Why it matters: beyond the debates about AI and originality, this is a clear example of assistive creativity—technology helping an artist keep working and preserving intent when physical ability changes. Nvidia’s AI boom and power In business and tech, Nvidia continues to look like a centerpiece of the AI buildout. A Fortune profile of CFO Colette Kress highlights how the company is steering through explosive growth as chips and data centers become core infrastructure for AI. Nvidia posted another huge quarter, and the big takeaway is how dependent major cloud providers have become on the company’s hardware to train and run AI systems. Nvidia is also reorganizing how it reports parts of the business, signaling it’s planning for an era where AI demand shapes nearly everything it does. Why it’s interesting: it’s a reminder that the AI boom isn’t just software—it’s also a massive, capital-heavy infrastructure race, with a few companies sitting at the center of the supply chain. Russia signs pact with Taliban Finally, a notable shift in regional security: Russia and Afghanistan’s Taliban authorities have signed a military-technical cooperation agreement on the sidelines of a security forum in Moscow. It’s being described as the Taliban’s first formal defense pact with any foreign country, covering areas like arms and technology exchanges. The symbolism is striking given the Soviet Union’s war in Afghanistan decades ago. Why it matters now: it points to changing power balances in South and Central Asia. The reporting suggests Pakistan’s influence in Afghanistan is under strain amid worsening border tensions and violence, while India may see strategic room to engage pragmatically with Kabul—especially given India’s longstanding ties with Russia. Whatever the motivations, the deal gives the Taliban more international legitimacy and new potential sources of equipment. Subscribe to edition specific feeds: - Space news * Apple Podcast English [https://apple.co/4cLLrdt] * Spotify English [https://spoti.fi/4jN8Dui] * RSS English [https://bit.ly/the_automated_daily_space] Spanish [https://theautomateddaily.com/space_es/feed.xml] French [https://theautomateddaily.com/space_fr/feed.xml] - Top news * Apple Podcast English [https://apple.co/3PTvdUF] Spanish [https://apple.co/3ECCMgk] French [https://apple.co/4hmcxbB] * Spotify English [https://spoti.fi/3ZYXAW2] Spanish [https://spoti.fi/414h4JD] French [https://spoti.fi/3Di0jDe] * RSS English [https://bit.ly/the_automated_daily_news] Spanish [https://bit.ly/the_automated_daily_news_es] French [https://bit.ly/the_automated_daily_news_fr] - Tech news * Apple Podcast English [https://apple.co/3RYWbg4] Spanish [https://apple.co/4i0WqRM] French [https://apple.co/4bEAXMm] * Spotify English [https://spoti.fi/3S089pG] Spanish [https://spoti.fi/3EE2Fwv] Spanish [https://spoti.fi/3DlObRE] * RSS English [https://bit.ly/the_automated_daily_tech] Spanish [https://bit.ly/the_automated_daily_tech_es] French [https://bit.ly/the_automated_daily_tech_fr] - Hacker news * Apple Podcast English [https://apple.co/48QWyzj] Spanish [https://apple.co/4ke9jtE] French [https://apple.co/41E1qFd] * Spotify English [https://spoti.fi/45zD1kf] Spanish [https://spoti.fi/4hF8h81] French [https://spoti.fi/3QY26Ak] * RSS English [https://bit.ly/the_automated_daily_hacker_news] Spanish [https://bit.ly/the_automated_daily_hacker_news_es] French [https://bit.ly/the_automated_daily_hacker_news_fr] - AI news * Apple Podcast English [https://apple.co/3M6Tg1o] Spanish [https://apple.co/4315L7Y] French [https://apple.co/3DkZbPb] * Spotify English [https://spoti.fi/3tzOfrz] Spanish [https://spoti.fi/416m40q] French [https://spoti.fi/41HuJGW] * RSS English [https://bit.ly/the_automated_daily_hackernews_ai] Spanish [https://bit.ly/the_automated_daily_hackernews_es_ai] French [https://bit.ly/the_automated_daily_hackernews_fr_ai] Visit our website at https://theautomateddaily.com/ [ https://theautomateddaily.com/] Send feedback to feedback@theautomateddaily.com Youtube [https://www.youtube.com/@TheAutomatedDaily] LinkedIn [https://www.linkedin.com/in/the-automated-daily/] X (Twitter) [https://x.com/automated_daily]

Gene test to skip chemo & Hepatitis B drug functional cure - News (May 30, 2026)

Please support this podcast by checking out our sponsors: - Discover the Future of AI Audio with ElevenLabs - https://try.elevenlabs.io/tad [https://try.elevenlabs.io/tad] - Effortless AI design for presentations, websites, and more with Gamma - https://try.gamma.app/tad [https://try.gamma.app/tad] - Lindy is your ultimate AI assistant that proactively manages your inbox - https://try.lindy.ai/tad [https://try.lindy.ai/tad] Support The Automated Daily directly: Buy me a coffee: https://buymeacoffee.com/theautomateddaily [https://buymeacoffee.com/theautomateddaily] TODAY'S TOPICS: GENE TEST TO SKIP CHEMO - A MAJOR OPTIMA TRIAL SUGGESTS THE PROSIGNA GENOMIC TEST CAN IDENTIFY HORMONE-POSITIVE BREAST CANCER PATIENTS WHO CAN SAFELY AVOID CHEMOTHERAPY, CUTTING TOXIC SIDE EFFECTS WHILE KEEPING OUTCOMES STRONG. HEPATITIS B DRUG FUNCTIONAL CURE - TWO INTERNATIONAL TRIALS REPORT BEPIROVIRSEN HELPED SOME CHRONIC HEPATITIS B PATIENTS REACH A “FUNCTIONAL CURE,” WITH SUSTAINED REMISSION AFTER STOPPING THERAPY—AN IMPORTANT SHIFT FROM LIFELONG SUPPRESSION. NERVE REGROWTH IN HUMAN ORGANOIDS - CAMBRIDGE RESEARCHERS LINKED BRAIN AND SPINAL CORD ORGANOIDS TO SHOW WHY NERVE REPAIR FADES WITH MATURITY, AND HOW BLOCKING KEY GENE REGULATORS PLUS A KNOWN DRUG CANDIDATE MAY RESTORE AXON REGROWTH. NATO COMMAND EXPANSION IN BALTICS - GERMANY AND THE NETHERLANDS WILL STAND UP A NEW NATO TACTICAL HEADQUARTERS NEAR ESTONIA AND LATVIA, AIMED AT FASTER DECISIONS AND STRONGER DETERRENCE AGAINST RUSSIA ON THE EASTERN FLANK. CANADA TRIBUNAL ON INDIGENOUS GENOCIDE - THE PERMANENT PEOPLES’ TRIBUNAL ISSUED AN INTERIM RULING CALLING CANADA’S CURRENT POLICIES AN ONGOING GENOCIDE AGAINST INDIGENOUS PEOPLES, INTENSIFYING DEBATE OVER ACCOUNTABILITY, RESIDENTIAL SCHOOLS, AND REFORM. US TAKES STAKES IN QUANTUM FIRMS - UNDER THE CHIPS AND SCIENCE ACT, THE US COMMERCE DEPARTMENT PLANS MINORITY EQUITY STAKES IN QUANTUM COMPUTING FIRMS, SIGNALING A NEW “GOVERNMENT-AS-SHAREHOLDER” APPROACH THAT COULD CHANGE HOW MARKETS PRICE RISK. INDIA’S PLAN FOR CHIP INDEPENDENCE - A NITI AAYOG REPORT SAYS INDIA’S SEMICONDUCTOR MARKET COULD REACH AROUND $200 BILLION BY 2035, BUT WARNS HEAVY IMPORT DEPENDENCE AND CALLS FOR MAJOR INVESTMENT ACROSS FABS, PACKAGING, AND TALENT. AI MEMORY BOOM RESHAPES PRICING - MICRON AND SK HYNIX HITTING TRILLION-DOLLAR VALUATIONS ALONGSIDE SAMSUNG SHOWS HOW AI DEMAND FOR HBM MEMORY IS TIGHTENING SUPPLY—AND COULD PUSH UP PRICES FOR PHONES, PCS, AND OTHER DEVICES. NVIDIA BETS BIG ON PHOTONICS - NVIDIA IS POURING BILLIONS INTO SILICON PHOTONICS TO REDUCE THE POWER AND HEAT LIMITS OF COPPER CONNECTIONS IN AI DATA CENTERS, BETTING OPTICAL LINKS WILL BE ESSENTIAL FOR SCALING FUTURE “AI FACTORY” SYSTEMS. AI TOOLS HELP DISABLED MUSICIANS - A PARKINSON’S-DIAGNOSED SINGER-SONGWRITER USED GENERATIVE AI TOOLS TO CREATE WORKABLE DEMO ARRANGEMENTS, SPOTLIGHTING AI AS AN ACCESSIBILITY TOOL EVEN AS COPYRIGHT AND TRAINING-DATA DISPUTES CONTINUE. Episode Transcript Gene test to skip chemo In health news, an international breast cancer trial is pointing toward a future where far fewer patients have to endure chemotherapy after surgery. The Optima study, run by University College London and involving more than four thousand patients, used a genomic test called Prosigna to read activity across a set of tumor genes and estimate recurrence risk. Patients who scored low largely received hormone therapy alone, and their outcomes were almost the same as those who went through the standard chemo-plus-hormone approach. Five years out, the low-score group that skipped chemo was about as likely to be alive and recurrence-free as the group that got it. If this holds up in guidelines, it’s a big deal: it shifts decisions away from broad, one-size-fits-many clinical factors and toward the biology of an individual tumor—while sparing people the long and sometimes lasting side effects of chemotherapy. Hepatitis B drug functional cure Another medical update could change the long-term outlook for chronic hepatitis B, a disease that typically means taking medication indefinitely. Results from two international trials suggest an experimental drug, bepirovirsen, helped some patients reach what researchers call a “functional cure”—meaning they could stop treatment without the virus roaring back, at least over the follow-up so far. Roughly one in five participants who got weekly injections for six months, alongside standard daily antivirals, stayed undetectable for at least six months after stopping everything. Researchers stress that longer follow-up is essential, and the trials didn’t include everyone—people with certain higher-risk conditions were excluded. Still, even partial success is notable in a disease that contributes to liver failure and cancer worldwide. Nerve regrowth in human organoids Researchers at the University of Cambridge have also delivered a fascinating clue about why injuries to the brain and spinal cord are so often permanent. They built connected “organoids”—miniature lab-grown versions of brain and spinal cord tissue—so nerve fibers could grow between them and even trigger contractions in small muscle-cell clusters. The key finding: young, still-developing neural circuits could regrow damaged connections for a time, but that ability dropped sharply as the neurons matured, echoing what’s seen in adult patients. The team also flagged a gene-regulation network that seems to flip nerve growth “off” as the system develops. Blocking parts of that network helped more mature neurons regain some ability to extend fibers after injury. A drug screen highlighted lynestrenol, an already approved hormone medication, as a candidate that boosted regrowth in this model. It’s not a ready-made cure—real injuries involve scarring and inflammation, and reconnecting nerves correctly is a massive challenge—but it’s a step toward therapies tested in human-like systems rather than relying only on animal models. NATO command expansion in Baltics Turning to security in Europe, Germany and the Netherlands say they’ll set up a joint NATO tactical headquarters in the Baltic region later this year. The command, linked to the German–Netherlands Corps, is expected to take on responsibilities focused on the Estonia–Latvia area, adding another major command layer beyond the existing headquarters in Poland. The practical point is speed and capacity: more planning power, more exercises, and more ability to coordinate large forces quickly if the situation deteriorates. The move comes amid persistent anxiety about hybrid threats in the region—things like suspected sabotage of undersea infrastructure and increased drone-related incidents—alongside NATO’s continuing effort to deter Russia without stumbling into escalation. Canada tribunal on Indigenous genocide In Canada, a “court of opinion” known as the Permanent Peoples’ Tribunal issued an interim ruling concluding that Canada’s current policies amount to an ongoing genocide against Indigenous Peoples. The hearings in Montreal were requested by the Native Women’s Shelter of Montreal and focused on missing Indigenous children and unmarked graves associated with the residential school system, alongside testimony about forced family separation, cultural destruction, and abuse. The federal government did not take part in the proceedings, while saying publicly it continues work on reconciliation and responses to the Truth and Reconciliation Commission’s Calls to Action. The tribunal’s final decision is expected on September 30th—Canada’s National Day for Truth and Reconciliation—keeping pressure on debates over accountability, denial, and the pace of reform. US takes stakes in quantum firms In US tech policy, the Commerce Department has signed letters of intent to put about two billion dollars into quantum computing and related hardware firms under the CHIPS and Science Act—but with a twist that grabbed Wall Street’s attention. Instead of typical research grants, the government plans to take minority equity stakes. The biggest headline is a billion-dollar commitment tied to a newly formed IBM quantum subsidiary, with additional planned support for firms including GlobalFoundries, Rigetti, D-Wave, Quantinuum, and Diraq. Supporters say the approach can provide stability and credibility to a risky but strategically important field, while critics warn it looks like the government picking winners and shielding investors from downside. Either way, it signals a shift: Washington may increasingly fund frontier tech not just as a sponsor, but as a shareholder. India’s plan for chip independence In India, a new report from NITI Aayog projects the country’s semiconductor market could grow to around two hundred billion dollars by 2035, driven by domestic demand. The report also highlights the current vulnerability: India imports the vast majority of the chips it uses, which drains foreign currency and leaves key industries exposed when global supply chains seize up. The proposed fix is expensive and long-term—hundreds of billions in cumulative investment across design, manufacturing, advanced packaging, materials, and infrastructure, with the government urged to shoulder a meaningful share to reduce risk for private investors. The big picture here is strategic: semiconductors are now treated like critical infrastructure, and countries want more control over the supply of the components that power everything from phones to defense systems. AI memory boom reshapes pricing On markets and manufacturing, the memory-chip industry just had a striking moment: Micron and SK Hynix surged to trillion-dollar valuations within days of each other, joining Samsung—meaning all three major memory makers briefly hit the milestone at once. What changed is AI. High-bandwidth memory, used in AI-focused graphics processors and accelerators, has turned a business once known for brutal oversupply cycles into a high-growth segment. The flip side is that as companies prioritize AI memory, supply of more traditional chips for everyday electronics can tighten. Industry leaders are warning demand could run ahead of supply for years, which raises the odds that consumers eventually feel it in the price of devices like PCs and smartphones. Nvidia bets big on photonics Nvidia is also placing a major bet on what comes next inside the data center: photonics, or using light to move data instead of electricity. Since March, Nvidia has committed at least six and a half billion dollars to companies building optical components and supply chains, arguing that copper connections are increasingly limited by power draw and heat as AI systems scale up. The company’s view is that future “AI factory” systems will need far more optical connectivity than the world can currently produce. The catch is manufacturing: making complex optical assemblies reliably and at scale is hard, and broader adoption could still be a couple of years away. But the direction is clear—if AI keeps growing, the plumbing that connects chips will matter almost as much as the chips themselves. AI tools help disabled musicians Finally, a story at the intersection of AI and accessibility: London singer-songwriter Samuel Smith, who was diagnosed with Parkinson’s disease in 2020, says generative AI music tools helped him finish his second album after tremors and fatigue made it difficult to play guitar. His approach wasn’t about dropping AI audio into the final tracks—he used tools to turn hummed ideas into rough demo arrangements that session musicians could then bring to life. It’s a reminder that while the industry argues over training data and copyright, there’s another angle: assistive creativity. For artists with illness or disability, these tools can act less like a shortcut and more like a bridge back into collaboration and production. Subscribe to edition specific feeds: - Space news * Apple Podcast English [https://apple.co/4cLLrdt] * Spotify English [https://spoti.fi/4jN8Dui] * RSS English [https://bit.ly/the_automated_daily_space] Spanish [https://theautomateddaily.com/space_es/feed.xml] French [https://theautomateddaily.com/space_fr/feed.xml] - Top news * Apple Podcast English [https://apple.co/3PTvdUF] Spanish [https://apple.co/3ECCMgk] French [https://apple.co/4hmcxbB] * Spotify English [https://spoti.fi/3ZYXAW2] Spanish [https://spoti.fi/414h4JD] French [https://spoti.fi/3Di0jDe] * RSS English [https://bit.ly/the_automated_daily_news] Spanish [https://bit.ly/the_automated_daily_news_es] French [https://bit.ly/the_automated_daily_news_fr] - Tech news * Apple Podcast English [https://apple.co/3RYWbg4] Spanish [https://apple.co/4i0WqRM] French [https://apple.co/4bEAXMm] * Spotify English [https://spoti.fi/3S089pG] Spanish [https://spoti.fi/3EE2Fwv] Spanish [https://spoti.fi/3DlObRE] * RSS English [https://bit.ly/the_automated_daily_tech] Spanish [https://bit.ly/the_automated_daily_tech_es] French [https://bit.ly/the_automated_daily_tech_fr] - Hacker news * Apple Podcast English [https://apple.co/48QWyzj] Spanish [https://apple.co/4ke9jtE] French [https://apple.co/41E1qFd] * Spotify English [https://spoti.fi/45zD1kf] Spanish [https://spoti.fi/4hF8h81] French [https://spoti.fi/3QY26Ak] * RSS English [https://bit.ly/the_automated_daily_hacker_news] Spanish [https://bit.ly/the_automated_daily_hacker_news_es] French [https://bit.ly/the_automated_daily_hacker_news_fr] - AI news * Apple Podcast English [https://apple.co/3M6Tg1o] Spanish [https://apple.co/4315L7Y] French [https://apple.co/3DkZbPb] * Spotify English [https://spoti.fi/3tzOfrz] Spanish [https://spoti.fi/416m40q] French [https://spoti.fi/41HuJGW] * RSS English [https://bit.ly/the_automated_daily_hackernews_ai] Spanish [https://bit.ly/the_automated_daily_hackernews_es_ai] French [https://bit.ly/the_automated_daily_hackernews_fr_ai] Visit our website at https://theautomateddaily.com/ [ https://theautomateddaily.com/] Send feedback to feedback@theautomateddaily.com Youtube [https://www.youtube.com/@TheAutomatedDaily] LinkedIn [https://www.linkedin.com/in/the-automated-daily/] X (Twitter) [https://x.com/automated_daily]

Webb spots outsized early black hole & GSK hepatitis B drug boosts cures - News (May 29, 2026)

Please support this podcast by checking out our sponsors: - Effortless AI design for presentations, websites, and more with Gamma - https://try.gamma.app/tad [https://try.gamma.app/tad] - Prezi: Create AI presentations fast - https://try.prezi.com/automated_daily [https://try.prezi.com/automated_daily] - Discover the Future of AI Audio with ElevenLabs - https://try.elevenlabs.io/tad [https://try.elevenlabs.io/tad] Support The Automated Daily directly: Buy me a coffee: https://buymeacoffee.com/theautomateddaily [https://buymeacoffee.com/theautomateddaily] TODAY'S TOPICS: WEBB SPOTS OUTSIZED EARLY BLACK HOLE - JAMES WEBB OBSERVATIONS OF A “LITTLE RED DOT” GALAXY SUGGEST A SUPERMASSIVE BLACK HOLE FORMED EXTREMELY EARLY—ABOUT 50 MILLION SOLAR MASSES AND UNUSUALLY DOMINANT. KEYWORDS: JWST, EARLY UNIVERSE, LITTLE RED DOTS, BLACK HOLE MASS, ABELL2744-QSO1. GSK HEPATITIS B DRUG BOOSTS CURES - NEW PHASE 3 DATA SHOW GSK’S BEPIROVIRSEN ACHIEVED A FUNCTIONAL CURE FOR CHRONIC HEPATITIS B IN ABOUT 1 IN 5 PATIENTS, FAR ABOVE TODAY’S TYPICAL CURE RATES. KEYWORDS: HEPATITIS B, BEPIROVIRSEN, PHASE 3, FUNCTIONAL CURE, FDA REVIEW. MELANOMA PEPTIDE MAY REVERSE RESISTANCE - UC SAN DIEGO RESEARCHERS REPORT THE PEPTIDE CATESTATIN SLOWED MELANOMA GROWTH AND APPEARED TO DIAL DOWN MECHANISMS LINKED TO THERAPY RESISTANCE IN LAB AND MOUSE STUDIES. KEYWORDS: MELANOMA, CATESTATIN, TREATMENT RESISTANCE, METASTASIS, ONCOGENESIS. ORGANOID STUDY HINTS NERVE REPAIR SWITCH - CAMBRIDGE SCIENTISTS CONNECTED HUMAN BRAIN AND SPINAL CORD ORGANOIDS AND IDENTIFIED A DEVELOPMENTAL “SWITCH” THAT SHUTS DOWN AXON REGROWTH—THEN PARTIALLY RE-ENABLED IT, INCLUDING WITH A KNOWN HORMONE DRUG. KEYWORDS: ORGANOIDS, AXON REGENERATION, SPINAL CORD INJURY, GENE REGULATION, LYNESTRENOL. WMO WARNS OF RECORD HEAT AHEAD - A NEW WMO AND U.K. MET OFFICE OUTLOOK SAYS THE NEXT FIVE YEARS ARE VERY LIKELY TO BE THE HOTTEST ON RECORD, WITH REPEATED BREACHES OF THE 1.5°C THRESHOLD AND FAST ARCTIC WARMING. KEYWORDS: WMO, 1.5°C, EL NIÑO, EXTREME HEAT, ARCTIC AMPLIFICATION. HORMUZ WAR STRAINS OIL MARKETS - A FOREIGN AFFAIRS ESSAY DESCRIBES A THREE-MONTH WAR INVOLVING THE U.S., ISRAEL, AND IRAN THAT HAS EFFECTIVELY CHOKED SHIPPING THROUGH THE STRAIT OF HORMUZ, TIGHTENING OIL SUPPLY AND RAISING PRESSURE FOR A LIMITED DEAL. KEYWORDS: STRAIT OF HORMUZ, OIL SUPPLY, BLOCKADE, MEDIATION, ENERGY MARKETS. GCHQ WARNS ON AI HYBRID THREATS - GCHQ CHIEF ANNE KEAST-BUTLER SAYS AI IS ACCELERATING CYBER AND INFLUENCE OPERATIONS THAT SIT BETWEEN PEACE AND WAR, WITH GROWING RISKS TO INFRASTRUCTURE, ELECTIONS, AND UNDERSEA CABLES. KEYWORDS: GCHQ, AI, HYBRID WARFARE, CRITICAL INFRASTRUCTURE, RUSSIA CHINA. GERMANY-NETHERLANDS NATO HQ IN BALTICS - GERMANY AND THE NETHERLANDS PLAN A NEW NATO TACTICAL HEADQUARTERS FOR THE BALTIC REGION TO SPEED COMMAND DECISIONS AND STRENGTHEN DETERRENCE ON THE EASTERN FLANK. KEYWORDS: NATO, BALTICS, DETERRENCE, GERMANY NETHERLANDS CORPS, ESTONIA LATVIA. Episode Transcript Webb spots outsized early black hole We’ll start in deep space, because this one is hard to ignore. Astronomers using the James Webb Space Telescope say they’ve mapped gas swirling around a supermassive black hole in a tiny early galaxy known as Abell2744-QSO1—seen as it was roughly 700 million years after the Big Bang. The striking part: they estimate the black hole weighs about 50 million Suns and accounts for roughly two-thirds of the entire system’s mass. In today’s Universe, black holes are massive, but they’re usually a small fraction of their host galaxy. Here, the black hole looks more like the main event than a side character—fueling a growing debate that some supermassive black holes may have formed first and helped assemble galaxies around them. GSK hepatitis B drug boosts cures In medical news, a major hepatitis B update could change what “treatable” means for millions of people. New Phase 3 results for GSK’s experimental drug bepirovirsen show a “functional cure” in about one in five patients with chronic infection—around 20% in one large study and 19% in another—while nobody on placebo hit that endpoint. That’s notable because today’s standard antivirals typically deliver functional cures in only a small slice of patients. With chronic hepatitis B affecting hundreds of millions worldwide and contributing to liver cancer and cirrhosis, even a minority cure rate at this level would be a meaningful step up. GSK has submitted the therapy for review to regulators including the FDA, so the next key question is whether these results translate into an approved new option in clinics. Melanoma peptide may reverse resistance Another health headline: researchers at UC San Diego say a naturally occurring peptide called catestatin may help slow melanoma and, importantly, may help counter a common problem—tumors that stop responding to standard targeted treatments. In lab experiments and mouse models, catestatin reduced tumor growth and seemed to curb behaviors linked to spread, like migration and invasiveness. The researchers also report that the peptide dampened gene activity tied to survival and drug resistance, and appeared to affect melanoma cells more than normal skin cells. It’s early-stage work, not a ready-to-prescribe therapy, but it adds to a broader theme in cancer research: looking for smarter ways to push back when tumors adapt and treatment options narrow. Organoid study hints nerve repair switch Staying with biomedical science, a team at the University of Cambridge has built connected human brain and spinal cord organoids—miniature tissue models—that can grow nerve fibers between them and even trigger contractions in nearby muscle-cell clusters. Their takeaway is both sobering and hopeful. They found that in younger, less mature neural circuits, damaged axons could regrow for a time, but that ability dropped sharply as the system matured—mirroring why adult brain and spinal cord injuries are so often permanent. The encouraging part: gene-activity signals pointed to a kind of developmental “off switch” that suppresses regrowth as neural connections mature. When the team blocked parts of that network, more mature neurons regained some ability to extend axons after injury, and a drug screen flagged an existing hormone medication, lynestrenol, as a candidate that boosted regrowth in this model. It’s not a cure for paralysis—but it is a clearer clue about what might be shutting human nerve repair down, and how that barrier might be nudged. WMO warns of record heat ahead Now to climate, where the next few years look increasingly tough to ignore. A new World Meteorological Organization report, produced with the U.K. Met Office, projects that the period from 2026 to 2030 is highly likely to be the hottest five-year stretch on record. The report puts strong odds on repeated crossings of the 1.5°C warming mark relative to pre-industrial levels, and warns that even small additional temperature increases stack risks quickly—more punishing heat waves, heavier floods, harsher droughts, and larger wildfire seasons, along with knock-on effects like food price shocks. The outlook is reinforced by forecasts of a strong El Niño developing and potentially persisting for years, which could push at least one year—possibly 2027—into new record territory. The report also highlights the Arctic, warming far faster than the global average, and warns about hotter, drier conditions in parts of the Amazon that could raise fire risk and weaken the rainforest’s role as a carbon sink. Hormuz war strains oil markets Turning to geopolitics and energy, a Foreign Affairs essay argues that after three months of war triggered by joint U.S.-Israeli attacks on Iran, the Trump administration is facing a painful problem: no clear off-ramp. The piece describes a standoff that has effectively shut the Strait of Hormuz to most shipping, removing a huge flow of Persian Gulf oil from global markets—roughly 14 million barrels per day, by the essay’s accounting. Despite heavy airstrikes, the authors say Iran’s government remains intact and defiant, raising doubts that further escalation will deliver decisive outcomes. They note that Pakistan is mediating diplomatic exchanges and that hints of a limited deal are emerging. The larger point is the obvious one: the longer the chokepoint stays squeezed, the more the economic pressure builds, and the harder it becomes to keep the conflict from widening. GCHQ warns on AI hybrid threats On security and technology, the head of the U.K.’s signals intelligence agency, GCHQ, Anne Keast-Butler, is warning that artificial intelligence is becoming an “unstoppable force” in modern conflict—especially in the grey zone between peace and war. Speaking at Bletchley Park, she said allies are seeing daily hybrid operations that target critical infrastructure, democratic processes, supply chains, and public trust—often calibrated to stay below the threshold that would trigger a traditional military response. She highlighted concerns around undersea cables and energy pipelines, and cautioned that Western countries could fall behind in cyberspace without faster action from governments and industry. The message is less about sci-fi and more about scale: AI can help attackers move faster, test more options, and create confusion more cheaply—raising the risk of miscalculation at a moment she called among the most dangerous of her career. Germany-Netherlands NATO HQ in Baltics And finally, an update from NATO’s eastern flank. Germany and the Netherlands say they will establish a joint tactical headquarters in the Baltic region this year, intended to help command forces and sharpen deterrence in the Estonia–Latvia area. The aim is added capacity and quicker decision-making, alongside existing NATO command structures, at a time when European officials have been increasingly concerned about sabotage risks and other hybrid threats across the region. In plain terms, this is about readiness and coordination—making it easier to move from planning and exercises to real-world command if the security situation deteriorates. Subscribe to edition specific feeds: - Space news * Apple Podcast English [https://apple.co/4cLLrdt] * Spotify English [https://spoti.fi/4jN8Dui] * RSS English [https://bit.ly/the_automated_daily_space] Spanish [https://theautomateddaily.com/space_es/feed.xml] French [https://theautomateddaily.com/space_fr/feed.xml] - Top news * Apple Podcast English [https://apple.co/3PTvdUF] Spanish [https://apple.co/3ECCMgk] French [https://apple.co/4hmcxbB] * Spotify English [https://spoti.fi/3ZYXAW2] Spanish [https://spoti.fi/414h4JD] French [https://spoti.fi/3Di0jDe] * RSS English [https://bit.ly/the_automated_daily_news] Spanish [https://bit.ly/the_automated_daily_news_es] French [https://bit.ly/the_automated_daily_news_fr] - Tech news * Apple Podcast English [https://apple.co/3RYWbg4] Spanish [https://apple.co/4i0WqRM] French [https://apple.co/4bEAXMm] * Spotify English [https://spoti.fi/3S089pG] Spanish [https://spoti.fi/3EE2Fwv] Spanish [https://spoti.fi/3DlObRE] * RSS English [https://bit.ly/the_automated_daily_tech] Spanish [https://bit.ly/the_automated_daily_tech_es] French [https://bit.ly/the_automated_daily_tech_fr] - Hacker news * Apple Podcast English [https://apple.co/48QWyzj] Spanish [https://apple.co/4ke9jtE] French [https://apple.co/41E1qFd] * Spotify English [https://spoti.fi/45zD1kf] Spanish [https://spoti.fi/4hF8h81] French [https://spoti.fi/3QY26Ak] * RSS English [https://bit.ly/the_automated_daily_hacker_news] Spanish [https://bit.ly/the_automated_daily_hacker_news_es] French [https://bit.ly/the_automated_daily_hacker_news_fr] - AI news * Apple Podcast English [https://apple.co/3M6Tg1o] Spanish [https://apple.co/4315L7Y] French [https://apple.co/3DkZbPb] * Spotify English [https://spoti.fi/3tzOfrz] Spanish [https://spoti.fi/416m40q] French [https://spoti.fi/41HuJGW] * RSS English [https://bit.ly/the_automated_daily_hackernews_ai] Spanish [https://bit.ly/the_automated_daily_hackernews_es_ai] French [https://bit.ly/the_automated_daily_hackernews_fr_ai] Visit our website at https://theautomateddaily.com/ [ https://theautomateddaily.com/] Send feedback to feedback@theautomateddaily.com Youtube [https://www.youtube.com/@TheAutomatedDaily] LinkedIn [https://www.linkedin.com/in/the-automated-daily/] X (Twitter) [https://x.com/automated_daily]

Vatican targets AI power & Single-shot cholesterol gene editing - News (May 27, 2026)

Please support this podcast by checking out our sponsors: - Prezi: Create AI presentations fast - https://try.prezi.com/automated_daily [https://try.prezi.com/automated_daily] - Discover the Future of AI Audio with ElevenLabs - https://try.elevenlabs.io/tad [https://try.elevenlabs.io/tad] - Lindy is your ultimate AI assistant that proactively manages your inbox - https://try.lindy.ai/tad [https://try.lindy.ai/tad] Support The Automated Daily directly: Buy me a coffee: https://buymeacoffee.com/theautomateddaily [https://buymeacoffee.com/theautomateddaily] TODAY'S TOPICS: VATICAN TARGETS AI POWER - POPE LEO XIV’S ENCYCLICAL “MAGNIFICA HUMANITAS” URGES AI TO BE “DISARMED,” WARNING ABOUT CONCENTRATED, OPAQUE AI POWER, INEQUALITY, MANIPULATION, AND HUMAN RIGHTS RISKS. SINGLE-SHOT CHOLESTEROL GENE EDITING - ELI LILLY SAYS VERVE’S VERVE-102 CUT LDL CHOLESTEROL BY 62% IN AN EARLY PHASE 1 UPDATE, REVIVING INTEREST IN ONE-TIME GENE-EDITING APPROACHES AFTER EARLIER SAFETY CONCERNS. GENE THERAPY FOR BRAIN RESILIENCE - UC SAN DIEGO RESEARCHERS REPORT SYNCAV1 GENE THERAPY PROTECTED MICE FROM TDP-43-LINKED BRAIN DAMAGE, A KEY PROTEIN IMPLICATED IN FRONTOTEMPORAL DEMENTIA, ALZHEIMER’S, AND ALS. AI PREDICTS CANCER TREATMENT RESPONSE - UC SAN DIEGO’S MUTATIONPROJECTOR USES FULL TUMOR MUTATION PATTERNS TO PREDICT IMMUNOTHERAPY AND CHEMOTHERAPY RESPONSE, AIMING TO EXPAND PRECISION ONCOLOGY BEYOND TODAY’S LIMITED BIOMARKERS. AI CHIPS RESHAPE SEMICONDUCTOR RACE - NVIDIA SIGNALED A BIGGER PUSH INTO DATA-CENTER CPUS FOR “AGENTIC AI,” MICRON’S RALLY REFLECTED AI-DRIVEN MEMORY DEMAND, AND HUAWEI CLAIMED A PATH TO ADVANCED CHIPS DESPITE SANCTIONS. US SCALES BACK NATO FORCES - DIPLOMATS SAY THE US TOLD NATO IT WILL GRADUALLY REDUCE CERTAIN EARMARKED AIRCRAFT AND NAVAL ASSETS, RAISING PRESSURE ON EUROPEAN ALLIES TO CLOSE CAPABILITY GAPS AND INVEST MORE. IRAN CEASEFIRE AND HORMUZ STAKES - PRESIDENT TRUMP SAID AN IRAN DEAL TO END THE 12-WEEK WAR IS LARGELY NEGOTIATED, WITH KEY QUESTIONS AROUND ENRICHED URANIUM, SANCTIONS RELIEF, AND REOPENING THE STRAIT OF HORMUZ. NASA’S PHASED MOON BASE PLAN - NASA REAFFIRMED A 2028 ASTRONAUT MOON RETURN GOAL AND LAID OUT A PHASED PLAN TOWARD A LASTING LUNAR BASE, LEANING HEAVILY ON COMMERCIAL PARTNERS AND STEP-BY-STEP CAPABILITY BUILDING. Episode Transcript Vatican targets AI power Let’s start with the Vatican, because this is not a place you usually look for the day’s biggest AI headline. Pope Leo XIV—now the first US-born pope—has made artificial intelligence a signature issue right out of the gate. His first encyclical, titled “Magnifica Humanitas,” argues AI should be “disarmed,” meaning stripped of uses that enable domination, exclusion, and even death. The Vatican is framing this as a moral and human-rights question, not a tech trend—warning that when AI power is concentrated and opaque, it can evade oversight and deepen inequality and manipulation. And in a very deliberate signal, the Vatican placed Anthropic cofounder Christopher Olah prominently during the rollout—an invitation for direct dialogue with Silicon Valley, not just governments. Single-shot cholesterol gene editing In health news, Eli Lilly is highlighting early results from a one-time gene-editing therapy aimed at lowering LDL, the so-called “bad” cholesterol. The treatment, VERVE-102—picked up through Lilly’s acquisition of Verve Therapeutics—showed a large LDL reduction at a higher dose in an early Phase 1 study, and the company said it did not see treatment-related serious adverse events in that initial group. That safety note is especially important because Verve previously shelved an earlier program after safety concerns. The big idea here is adherence: many patients struggle to stay consistent on chronic cholesterol meds, so a single-shot approach—if it holds up in larger and longer trials—could shift prevention from daily discipline to a one-and-done intervention. For now, it’s still preliminary, but it’s another sign Lilly is serious about expanding into genetic medicines. Gene therapy for brain resilience Staying with biology, UC San Diego researchers reported an experimental gene therapy that, in mice, appeared to protect the brain from damage linked to TDP-43—a toxic protein buildup strongly tied to frontotemporal dementia and also common in Alzheimer’s and ALS. What’s interesting is the strategy: instead of only trying to remove toxic proteins, this approach aims to boost the brain’s resilience. The therapy delivers a payload designed to increase a protective protein called caveolin-1, and the team says treated mice preserved key behaviors tied to learning and memory, while showing less TDP-43 pathology in regions like the cortex and hippocampus. It’s still preclinical, but the “help neurons withstand stress” angle could be relevant across multiple neurodegenerative diseases—an area where breakthroughs have been hard to come by. AI predicts cancer treatment response And another UC San Diego development sits at the intersection of medicine and AI: a model called MutationProjector that uses a tumor’s overall pattern of DNA mutations to predict how cancers might respond to immunotherapy and chemotherapy. The researchers trained it on genomic profiles from tens of thousands of tumors across several common solid cancers, then tested it on independent patient groups where it matched or beat existing prediction methods. The practical takeaway is straightforward: sequencing tumors is increasingly routine, but only a small share of patients currently get matched to treatments based on genetics. Tools that make the full mutation “signature” clinically useful could widen the reach of precision oncology—without relying on a single rare mutation to tell the whole story. AI chips reshape semiconductor race Now to the business of AI—starting with chips. Nvidia reported another strong quarter and upbeat guidance, but the more notable surprise was strategic: CEO Jensen Huang said the company is making a major push into data-center CPUs, positioning them as crucial for what Nvidia calls “agentic AI,” where systems need more coordination and control around AI workloads. Nvidia is essentially signaling it wants a bigger slice of the data-center stack, not just the GPU layer. If it follows through, this becomes a direct pressure point on incumbents like Intel and a fresh competitive challenge for AMD in the server market. US scales back NATO forces That broader AI buildout is also lifting the memory side of the chip world. Micron’s shares surged, briefly pushing it into the rarefied air of a trillion-dollar valuation, after a bullish call argued the company could secure longer-term memory supply agreements with major AI buyers. Memory has historically been boom-and-bust, but the market is betting that AI demand—especially from giant data centers—could smooth out some of that volatility and keep pricing firmer for longer. It’s a big shift in narrative: from “cyclical commodity” to “strategic bottleneck.” Iran ceasefire and Hormuz stakes And then there’s China’s push to keep advancing under restrictions. Huawei claimed it has a new chip-design approach that could help it reach near cutting-edge semiconductor capabilities within about five years, despite US sanctions that limit access to the most advanced manufacturing tools and software. The company is pitching a path that relies more on stacking and three-dimensional design tricks rather than purely shrinking transistors the traditional way. There’s no independent performance proof yet, and major obstacles remain—especially around heat, cost, and design tooling—but the message is clear: Huawei wants investors, customers, and Beijing to believe China can narrow the gap, even with the door partially closed. NASA’s phased Moon base plan In security and diplomacy, US officials have told NATO allies they plan to gradually reduce some of the forces and major assets the United States earmarks for the alliance, according to diplomats briefed on a closed-door meeting. The Pentagon reportedly emphasized that nuclear deterrence arrangements would not change, but the direction fits President Trump’s push to scale back America’s role in NATO and shift attention toward other regions, including the Indo-Pacific. For Europe, the significance is less about symbolism and more about capability gaps: certain high-end assets are hard to replace quickly, so this could accelerate pressure on European allies to build up their own defenses rather than assuming US backfill. Story 9 Also on geopolitics, President Trump says a deal with Iran to end the 12-week war is “largely negotiated,” though officials caution timing and details are still unclear. Reports suggest the draft framework would aim to end fighting across the region, curb interference through proxy networks, and—crucially for the global economy—move toward restoring traffic through the Strait of Hormuz as the US ends its blockade of Iran’s ports. Another major element would involve Iran giving up its stockpile of highly enriched uranium, with sanctions relief tied to compliance. The stakes are enormous because Hormuz is a choke point for global energy shipments, and any durable calm there could quickly ripple into oil prices and shipping stability. Story 10 Finally, to space: NASA says it still aims to return astronauts to the Moon in 2028 and ultimately build a permanent lunar base, with a phased plan stretching into the next decade. The near-term focus is proving transport reliability and running early survival-and-infrastructure experiments before moving to more permanent systems. NASA also underscored that it’s leaning heavily on commercial partners to deliver cargo, science payloads, and exploration tools—part of a broader push toward a sustainable “lunar economy.” The point isn’t just flags and footprints; it’s learning how to operate in extreme radiation, temperature swings, and harsh terrain in a way that can be repeated—and scaled. Subscribe to edition specific feeds: - Space news * Apple Podcast English [https://apple.co/4cLLrdt] * Spotify English [https://spoti.fi/4jN8Dui] * RSS English [https://bit.ly/the_automated_daily_space] Spanish [https://theautomateddaily.com/space_es/feed.xml] French [https://theautomateddaily.com/space_fr/feed.xml] - Top news * Apple Podcast English [https://apple.co/3PTvdUF] Spanish [https://apple.co/3ECCMgk] French [https://apple.co/4hmcxbB] * Spotify English [https://spoti.fi/3ZYXAW2] Spanish [https://spoti.fi/414h4JD] French [https://spoti.fi/3Di0jDe] * RSS English [https://bit.ly/the_automated_daily_news] Spanish [https://bit.ly/the_automated_daily_news_es] French [https://bit.ly/the_automated_daily_news_fr] - Tech news * Apple Podcast English [https://apple.co/3RYWbg4] Spanish [https://apple.co/4i0WqRM] French [https://apple.co/4bEAXMm] * Spotify English [https://spoti.fi/3S089pG] Spanish [https://spoti.fi/3EE2Fwv] Spanish [https://spoti.fi/3DlObRE] * RSS English [https://bit.ly/the_automated_daily_tech] Spanish [https://bit.ly/the_automated_daily_tech_es] French [https://bit.ly/the_automated_daily_tech_fr] - Hacker news * Apple Podcast English [https://apple.co/48QWyzj] Spanish [https://apple.co/4ke9jtE] French [https://apple.co/41E1qFd] * Spotify English [https://spoti.fi/45zD1kf] Spanish [https://spoti.fi/4hF8h81] French [https://spoti.fi/3QY26Ak] * RSS English [https://bit.ly/the_automated_daily_hacker_news] Spanish [https://bit.ly/the_automated_daily_hacker_news_es] French [https://bit.ly/the_automated_daily_hacker_news_fr] - AI news * Apple Podcast English [https://apple.co/3M6Tg1o] Spanish [https://apple.co/4315L7Y] French [https://apple.co/3DkZbPb] * Spotify English [https://spoti.fi/3tzOfrz] Spanish [https://spoti.fi/416m40q] French [https://spoti.fi/41HuJGW] * RSS English [https://bit.ly/the_automated_daily_hackernews_ai] Spanish [https://bit.ly/the_automated_daily_hackernews_es_ai] French [https://bit.ly/the_automated_daily_hackernews_fr_ai] Visit our website at https://theautomateddaily.com/ [ https://theautomateddaily.com/] Send feedback to feedback@theautomateddaily.com Youtube [https://www.youtube.com/@TheAutomatedDaily] LinkedIn [https://www.linkedin.com/in/the-automated-daily/] X (Twitter) [https://x.com/automated_daily]

Single-shot gene editing for LDL & Vatican calls for AI laws - News (May 26, 2026)

Please support this podcast by checking out our sponsors: - Effortless AI design for presentations, websites, and more with Gamma - https://try.gamma.app/tad [https://try.gamma.app/tad] - Prezi: Create AI presentations fast - https://try.prezi.com/automated_daily [https://try.prezi.com/automated_daily] - Invest Like the Pros with StockMVP - https://www.stock-mvp.com/?via=ron [https://www.stock-mvp.com/?via=ron] Support The Automated Daily directly: Buy me a coffee: https://buymeacoffee.com/theautomateddaily [https://buymeacoffee.com/theautomateddaily] TODAY'S TOPICS: SINGLE-SHOT GENE EDITING FOR LDL - ELI LILLY SAYS VERVE-102, A ONE-TIME GENE-EDITING THERAPY, CUT LDL “BAD” CHOLESTEROL BY ABOUT 62% IN AN EARLY TRIAL—AN INTRIGUING POTENTIAL ALTERNATIVE TO DAILY PILLS. VATICAN CALLS FOR AI LAWS - POPE LEO XIV’S FIRST ENCYCLICAL, “MAGNIFICA HUMANITAS,” URGES STRONG AI REGULATION, INDEPENDENT OVERSIGHT, AND CLEAR ACCOUNTABILITY—ESPECIALLY FOR MILITARY USES AND LABOR IMPACTS. U.S.-IRAN TALKS AND HORMUZ REOPENING - OFFICIALS SAY A U.S.-IRAN FRAMEWORK COULD END THE CONFLICT, REOPEN THE STRAIT OF HORMUZ, AND REQUIRE IRAN TO DISPOSE OF HIGHLY ENRICHED URANIUM, WITH SANCTIONS RELIEF TIED TO VERIFICATION. HUAWEI’S CLAIMED CHIP DESIGN LEAP - HUAWEI CLAIMS A PATH TO NEAR CUTTING-EDGE CHIPS WITHIN YEARS USING ADVANCED 3D-STYLE DESIGN IDEAS, SIGNALING CHINA’S PUSH FOR SEMICONDUCTOR SELF-RELIANCE UNDER U.S. RESTRICTIONS. AI COPILOTS MOVE TOWARD FLIGHTS - MERLIN LABS IS TESTING AI ASSISTANCE FOR PILOTS AND HAS A MAJOR U.S. AIR FORCE CONTRACT, HIGHLIGHTING GROWING INTEREST IN AUTOMATION FOR CARGO AND OTHER LOWER-RISK MISSIONS. CELL THERAPY SHOWS PROMISE FOR CIRRHOSIS - A SCOTTISH TRIAL REPORTED BETTER TRANSPLANT-FREE SURVIVAL FOR ADVANCED LIVER DISEASE USING A PATIENT-DERIVED MACROPHAGE CELL THERAPY, POTENTIALLY EASING PRESSURE FROM ORGAN SHORTAGES. NEW MONITORING AND EARLY CANCER CLUES - RESEARCHERS HIGHLIGHTED TOOLS THAT COULD CHANGE ROUTINE CARE: A WEARABLE ULTRASOUND PATCH FOR LONGER FETAL MONITORING, PLUS EVIDENCE THAT GLP-1 DRUGS MAY CORRELATE WITH SLOWER CANCER SPREAD AND A URINE TEST THAT MAY SPOT LUNG CANCER EARLIER. Episode Transcript Single-shot gene editing for LDL We start with the biggest geopolitical and economic pressure point of the moment: the Strait of Hormuz. Regional officials speaking to the AP say the U.S. is close to a deal with Iran that could end the current war, reopen that critical shipping route, and—most notably—require Tehran to give up its stockpile of highly enriched uranium. The outlines being discussed reportedly include a short window to finalize details, with sanctions relief tied to Iran actually disposing of that material, potentially through dilution or transfer to a third country. Why it matters: when Hormuz is disrupted, global energy prices and shipping insurance don’t just wobble—they lurch. A phased reopening would aim to calm markets, while the nuclear component could reshape the next chapter of nonproliferation diplomacy. But there’s a clear note of caution too: President Donald Trump says he’s urging negotiators not to rush, which signals the political risk of settling for a deal that doesn’t hold up under scrutiny. Vatican calls for AI laws Next, a major intervention in the global debate over artificial intelligence—from the Vatican. Pope Leo XIV has released his first encyclical, titled “Magnifica Humanitas,” calling for strong legal regulation of AI, not just voluntary ethics. He argues that when a small number of private companies control massive amounts of data and computing power, society can’t rely on good intentions alone. One of the sharpest points is about warfare: the pope says it’s unacceptable to hand irreversible lethal decisions to machines, and he demands transparency and accountability in any AI-enabled military chain of command. He also warns that AI could displace work at scale, and that economic incentives should not outrank human dignity. This is interesting because it’s not a generic “be careful with tech” message. It’s a direct push for enforceable rules—landing as policymakers worldwide struggle to keep pace with rapidly advancing systems. U.S.-Iran talks and Hormuz reopening From AI rules to the hardware race: Huawei is claiming it has a new approach to chip design that could let it reach near cutting-edge performance within several years, despite U.S. sanctions that limit China’s access to the most advanced chipmaking tools. Huawei’s pitch is, essentially, a different route up the mountain: instead of depending mainly on ever-smaller traditional designs, the company says it can stack and arrange circuits in new three-dimensional ways and focus on speeding data movement within the chip. Analysts, though, are urging caution—because making advanced designs work reliably at scale brings real-world challenges like heat, power use, manufacturing yield, and software tooling. The significance is straightforward: if Huawei’s approach holds up, it strengthens China’s push for semiconductor self-reliance and could change the competitive landscape for AI computing—especially as U.S. export controls squeeze what American suppliers can sell into China. Huawei’s claimed chip design leap Staying with AI, but shifting to the skies: Boston startup Merlin Labs says it’s testing an AI system designed to be installed on existing aircraft to assist with flying—handling routine tasks, supporting decisions about routing and weather, and communicating with air traffic control. The company says it has completed hundreds of test flights, but passenger use is still years away. Merlin’s message is incrementalism: this is positioned as a safety-focused copilot first, not a near-term replacement for humans. Even so, the military interest is real. Merlin has also landed a sizable U.S. Air Force contract aimed at eventually operating cargo aircraft without pilots onboard. Why this matters: aviation is one of the most regulated safety-critical domains on Earth. If credible automation expands there—even starting with cargo and lower-risk missions—it can ripple across pilot training, airline operations, and the economics of air transport. AI copilots move toward flights Now to the health story we teased at the top: Eli Lilly says an experimental one-time gene-editing therapy it picked up through its acquisition of Verve Therapeutics cut LDL “bad” cholesterol by about 62% at a higher dose in an early clinical study. Lilly also says no treatment-related serious adverse events were seen in this initial dataset—an important point after Verve previously dropped an earlier cholesterol-editing program over safety concerns. The big idea here is adherence. Cholesterol-lowering drugs work well, but many people don’t take them consistently for years and years. A one-and-done approach, if it proves safe and durable, could change prevention at a population scale. But the caveat is just as important as the promise: these are early, safety-focused results. The real test is whether the benefits last, and whether larger trials reveal rarer risks. Cell therapy shows promise for cirrhosis Another medical development worth watching: researchers in Scotland reported multi-year results for a macrophage-based cell therapy aimed at advanced liver disease and cirrhosis—conditions where transplant is often the only definitive option. In a relatively small trial, patients who received the cell therapy were more likely to be alive years later without needing a transplant compared with those getting standard care, and researchers reported no serious side effects linked to the treatment. The therapy uses a patient’s own immune cells, prepares them, and sends them back in with the goal of reducing scarring and supporting repair. Why it’s interesting: transplant waiting lists are constrained by donor shortages, and late diagnosis is common. Even a therapy that delays or prevents the need for a transplant could have outsized impact for patients and health systems—if larger trials confirm the benefit. New monitoring and early cancer clues We’ll close with a rapid round of health research that could influence everyday care. First, cancer and metabolic drugs: new observational data being presented at ASCO suggests people with certain solid tumors who started GLP-1 medicines—drugs best known for diabetes and weight loss—had lower rates of cancer spread compared with similar patients on other diabetes medications. Researchers stress this can’t prove cause and effect, but the signal is consistent enough that it strengthens the case for randomized trials. If confirmed, it would matter for patients juggling diabetes and cancer, and it could open new research into how metabolism and inflammation shape tumor behavior. Second, early detection: UK researchers backed by Cancer Research UK describe a potential urine test for earlier lung cancer detection by looking for protein signals tied to senescent, or “zombie,” cells associated with early tumor development. The hope is a simple screening tool that catches disease before symptoms—when treatment has a much better chance. And third, pregnancy monitoring: a wearable ultrasound patch has been demonstrated as a way to continuously image a fetus for hours and track blood flow in real time. In early trials, the readings matched conventional ultrasound snapshots, and continuous monitoring in at least one high-risk case reportedly helped clinicians act quickly. It’s still a proof-of-concept and not yet a home-ready device, but the direction is clear: longer, more informative monitoring could help spot complications that short, occasional scans might miss. Subscribe to edition specific feeds: - Space news * Apple Podcast English [https://apple.co/4cLLrdt] * Spotify English [https://spoti.fi/4jN8Dui] * RSS English [https://bit.ly/the_automated_daily_space] Spanish [https://theautomateddaily.com/space_es/feed.xml] French [https://theautomateddaily.com/space_fr/feed.xml] - Top news * Apple Podcast English [https://apple.co/3PTvdUF] Spanish [https://apple.co/3ECCMgk] French [https://apple.co/4hmcxbB] * Spotify English [https://spoti.fi/3ZYXAW2] Spanish [https://spoti.fi/414h4JD] French [https://spoti.fi/3Di0jDe] * RSS English [https://bit.ly/the_automated_daily_news] Spanish [https://bit.ly/the_automated_daily_news_es] French [https://bit.ly/the_automated_daily_news_fr] - Tech news * Apple Podcast English [https://apple.co/3RYWbg4] Spanish [https://apple.co/4i0WqRM] French [https://apple.co/4bEAXMm] * Spotify English [https://spoti.fi/3S089pG] Spanish [https://spoti.fi/3EE2Fwv] Spanish [https://spoti.fi/3DlObRE] * RSS English [https://bit.ly/the_automated_daily_tech] Spanish [https://bit.ly/the_automated_daily_tech_es] French [https://bit.ly/the_automated_daily_tech_fr] - Hacker news * Apple Podcast English [https://apple.co/48QWyzj] Spanish [https://apple.co/4ke9jtE] French [https://apple.co/41E1qFd] * Spotify English [https://spoti.fi/45zD1kf] Spanish [https://spoti.fi/4hF8h81] French [https://spoti.fi/3QY26Ak] * RSS English [https://bit.ly/the_automated_daily_hacker_news] Spanish [https://bit.ly/the_automated_daily_hacker_news_es] French [https://bit.ly/the_automated_daily_hacker_news_fr] - AI news * Apple Podcast English [https://apple.co/3M6Tg1o] Spanish [https://apple.co/4315L7Y] French [https://apple.co/3DkZbPb] * Spotify English [https://spoti.fi/3tzOfrz] Spanish [https://spoti.fi/416m40q] French [https://spoti.fi/41HuJGW] * RSS English [https://bit.ly/the_automated_daily_hackernews_ai] Spanish [https://bit.ly/the_automated_daily_hackernews_es_ai] French [https://bit.ly/the_automated_daily_hackernews_fr_ai] Visit our website at https://theautomateddaily.com/ [ https://theautomateddaily.com/] Send feedback to feedback@theautomateddaily.com Youtube [https://www.youtube.com/@TheAutomatedDaily] LinkedIn [https://www.linkedin.com/in/the-automated-daily/] X (Twitter) [https://x.com/automated_daily]